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Objectives The purpose of this study was to invasively investigate the hemodynamic response to exercise in patients with
heart failure with normal ejection fraction (HFNEF) and to evaluate the ability of the peak early diastolic transmi-
tral velocity to peak early diastolic annular velocity ratio (E/e=) to reflect exercise hemodynamics.
Background There is little information regarding the hemodynamic response to exercise in HFNEF.
Methods Patients with HFNEF (n  14) and asymptomatic controls (n  8) underwent right-side heart catheterization at
rest and during supine cycle ergometer exercise and echocardiography with measurement of resting and peak
exercise E/e=.
Results Resting pulmonary capillary wedge pressure (PCWP) (10  4 mm Hg vs. 10  4 mm Hg; p  0.94) was similar
in HFNEF patients and controls, but stroke volume index (SVI) (p  0.02) was lower, and systemic vascular resis-
tance index (SVRI) (p  0.01) was higher in patients. Patients stopped exercise at lower work rate (0.63  0.29
W/kg vs. 1.13  0.49 W/kg; p  0.006). Although peak exercise PCWP was similar in both groups (23 6 mm Hg
vs. 20  7 mm Hg; p  0.31), the peak PCWP/work rate ratio was higher in patients compared with controls
(46  31 mm Hg/W/kg vs. 20  9 mm Hg/W/kg; p  0.03). Peak exercise SVI (p  0.001) was lower and SVRI
was higher (p  0.01) in patients. Resting E/e= was modestly elevated in patients (13.2  4.1 vs. 9.5  3.4;
p  0.04). Peak exercise E/e= did not differ between the groups (11.1  3.4 vs. 9.4  3.4; p  0.28).
Conclusions The HFNEF patients achieved a similar peak exercise PCWP to that of asymptomatic controls, at a much lower
workload. This occurs at a lower SVI and in the setting of higher SVRI. The E/e= does not reflect the hemody-
namic changes during exercise in HFNEF patients. (J Am Coll Cardiol 2010;56:855–63) © 2010 by the
American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.04.040a
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the diagnosis of heart failure is essentially made on the
asis of both the presence of a constellation of symptoms in
hich exercise intolerance due to dyspnea is a key feature,
nd the demonstration of impaired left ventricular (LV)
unction (1). A large body of evidence now indicates that in
pproximately 50% of patients with heart failure the left
entricular ejection fraction (LVEF) is normal, termed
eart failure with normal ejection fraction (HFNEF) (2).
FNEF patients may be as symptomatically limited as
From the Heart Failure Research Group, Baker IDI Heart and Diabetes Institute,
elbourne, Australia; †Heart Center, Alfred Hospital, Melbourne, Australia; ‡Allergy,
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tudy was supported by a Program Grant (to Dr. Kaye) from the National Health and
edical Research Council of Australia, Canberra, Australia, and the Swiss National
cience Foundation, Berne, Switzerland, Grant PBZHB-121007 (to Dr. Maeder). All
ther authors have reported that they have no relationships to disclose.p
Manuscript received January 25, 2010; revised manuscript received March 25,
010, accepted April 12, 2010.re heart failure patients with reduced LVEF (3), and
heir survival is reduced in comparison with age-matched
ontrols (4).
To date, little progress has been made with regard to the
evelopment of specific treatments for HFNEF (5–7).
ccordingly, a major imperative exists for the detailed
haracterization of the key causes of symptoms in HFNEF.
See page 864
lthough the majority of patients with HFNEF have symp-
oms only on exertion, very little detailed data exists regarding
he hemodynamic response to exercise in these patients.
hereas recent noninvasive studies have shed more light on
V mechanics during exercise (8,9), fundamental questions on
he exercise response in HFNEF remain unanswered. Sophis-
icated studies using LV conductance catheters and right atrial
acing to mimic exercise demonstrated a decrease in LV
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Exercise Hemodynamics in HFNEF September 7, 2010:855–63end-diastolic pressure and stroke
volume at higher heart rates (10,11),
whereas noninvasive studies re-
vealed varying stroke volume re-
sponses to exercise (8,9,12). A
wide range of causative mecha-
nisms for HFNEF have been pro-
posed, including altered diastolic
performance (13), LV systolic dys-
function (9,14), altered ventriculo-
vascular coupling (15), impaired
vasodilator reserve (12), chrono-
tropic incompetence (12), and in-
creased pulmonary vascular reac-
tivity (16).
Given the ongoing uncertainty
about the pathophysiology of
HFNEF, we aimed to invasively
investigate the hemodynamic re-
sponse to cycle ergometer exer-
cise in patients with suspected
HFNEF in comparison with
asymptomatic control subjects.
In conjunction, we evaluated the
ability of noninvasive measures
to accurately reflect the hemody-
namic profile during exercise.
ethods
atients and protocol. Between September 2008 and Au-
ust 2009, we studied 14 patients with suspected HFNEF
nd 8 control subjects. Patients with HFNEF underwent
ight-side heart catheterization for evaluation of exercise
ntolerance corresponding to a New York Heart Association
NYHA) functional class II or III as well as objective
vidence of impaired exercise capacity as assessed by cardio-
ulmonary exercise testing, treadmill exercise tests, or 6-min
alking tests. None of the patients reported angina, and all
articipants either had a negative stress echocardiogram, a
egative myocardial perfusion scan, or a negative exercise
lectrocardiogram. Patients without sinus rhythm and pa-
ients with left bundle branch block, cardiomyopathies,
ore than mild valvular heart disease, LVEF 50%, and a
orced expiratory volume within 1 s less than the lower limit
f normal were excluded. These criteria are in accordance
ith those from recently published mechanistic studies on
FNEF (8,9,11). Similar to these studies, the presence of
V diastolic dysfunction as defined by recent recommenda-
ions (17) was not an inclusion criterion. Control subjects
atched for age, sex, and blood pressure with subjectively
ormal exercise tolerance were recruited by advertisement
nd from outpatient clinics.
All studies were performed in the nonfasting state and
nder full medication if applicable. All participants under-
Abbreviations
and Acronyms
E  peak early diastolic
transmitral velocity
e=septal/lateral/av  peak
early diastolic mitral
annular velocities at septal
and lateral annulus and
averaged value
HFNEF  heart failure with
normal ejection fraction
LV  left ventricular
LVEF  left ventricular
ejection fraction
NYHA  New York Heart
Association
PCWP  pulmonary
capillary wedge pressure
s=septal/lateral/av  peak
systolic mitral annular
velocities at the septal and
lateral annulus and the
averaged value
SVI  stroke volume index
SVRI  systemic vascular
resistance index
VO2  oxygen uptakeent transthoracic echocardiography at rest (full study) and turing exercise (measurement of the peak early diastolic
ransmitral velocity [E] to peak early diastolic annular
elocity [e=] ratio [E/e=] simultaneously with invasive he-
odynamic measurements), and resting and exercise right-
ide heart catheterization. Ten HFNEF patients and all
ontrols also underwent maximal cardiopulmonary exercise
esting on a separate day. The study was approved by the
thics committee of the Alfred Hospital, and all participants
rovided written informed consent.
chocardiography. Echocardiograms were obtained by 1
ingle experienced echocardiographer, using standard views
n accordance with current guidelines (18,19). Measure-
ents were performed off-line by a single reader. All
eported measurements were averaged from 3 cycles.
ulsed-wave Doppler recordings of transmitral inflow were
btained between the mitral leaflet tips from the apical
-chamber view to assess E and the peak late diastolic
ransmitral velocity and deceleration time. Peak systolic
nd peak early diastolic mitral annular velocities were
easured by pulsed wave tissue Doppler at the septal and
ateral annulus, and averaged values were also calculated
s=septal/lateral/av and e=septal/lateral/av) (19). The E/e= ratio
as calculated for the septal (E/e=septal) and the lateral
E/e=lateral) annulus as well as based on e=av (E/e=av).
ardiac catheterization. Cardiac catheterization was per-
ormed immediately after the resting echocardiogram. A
-F arterial line was placed in a radial or brachial artery for
lood pressure measurement and blood sampling. A
alloon-tipped pulmonary artery catheter (7-F) was inserted
hrough an introducer sheath placed in the right internal
ugular or a brachial vein for measurement of right atrial
ressure, pulmonary artery pressure, and pulmonary capillary
edge pressure (PCWP). The wedge position was confirmed
y fluoroscopy and pressure wave form, and the mean PCWP
as measured at end expiration. Cardiac output was measured
sing thermodilution with measurements taken in triplicate.
easurements were indexed to body surface area, as appropriate.
ata on stroke volume index (SVI) refer to thermodilution-
erived values throughout the paper.
Subjects then started to exercise in the supine position on
cycle ergometer mounted to the catheter table at a work
ate of 0.3  0.1 W/kg body weight. Where this was the
aximal symptom-limited work rate (8 HFNEF patients),
emodynamics were measured 3 min after the commence-
ent of exercise. For the remaining patients, the work
ate was increased to a second stage that corresponded
t least to submaximal exercise (1.0  0.2 W/kg in
HFNEF patients and 7 controls, and 1.5 W/kg in
control) with hemodynamic measures obtained after
min. Measurements of exercise E and e=septal were
btained simultaneously with invasive measurements.
rterial and mixed venous blood samples were obtained
t rest and peak exercise for blood gas analysis. Arterio-
enous differences in oxygen content and oxygen uptake
VO2) at rest and peak exercise were calculated according
o the Fick principle from thermodilution-derived cardiac
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September 7, 2010:855–63 Exercise Hemodynamics in HFNEFutput, arterial and mixed venous oxygen saturations, and
emoglobin.
ardiopulmonary exercise testing. On a separate day,
ubjects underwent maximal upright cardiopulmonary exer-
ise testing on an electronically braked cycle ergometer
sing step protocols with 5- to 15-W increments every
inute. Minute ventilation, VO2, and carbon dioxide out-
ut were obtained breath by breath and averaged at 30-s
ntervals (SensorMedics, Yorba Linda, California). Peak
O2 was defined as the maximum 30 s VO2 average. The
lope of the ventilation to carbon dioxide output relation-
hip was calculated from all data points from the beginning
o the end of exercise.
atriuretic peptides. The B-type natriuretic peptide
ARCHITECT BNP assay, Abbott, Abbott Park, Illinois)
nd the N-terminal pro–B-type natriuretic peptide (Roche
lecsys proBNP assay on the E170 analyzer, Roche, Basel,
witzerland) were measured using commercially available
ssays.
tatistical analysis. Categorical data are given as counts
nd percentages, and comparisons between groups were
erformed using chi-square tests. Continuous data are
resented as mean  SD or median (range), as appropriate.
omparisons between groups were performed using unpaired
tests and Mann-Whitney U tests, respectively, and resting
nd peak exercise measurements were compared using paired t
ests. To assess the impact of exercise on heart rate and the
O2/work rate relationship at matched work rates, analysis of
linical Characteristics ofatients With HFNEF and ControlsTable 1 Clinical Characteristics ofPatients With HFNEF and Controls
HFNEF
(n  14)
Controls
(n  8) p Value
Age, yrs 69 10 61 12 0.12
Sex, male/female 9 (64%)/5 (36%) 5 (63%)/3 (37%) 0.93
Body mass index, kg/m2 29.6 4.6 25.0 5.1 0.046
Diabetes mellitus 2 (14%) 0
Medication
Aspirin 3 (21%) 0
Warfarin 2 (14%) 0
Statin 3 (21%) 0
ACEI/ARB 8 (57%) 0
Beta-blocker 5 (36%) 0
Ca2 blocker 8 (57%) 0
Diuretic 4 (29%) 0
Symptoms 0.001
NYHA functional class II 6 (43%) 0
NYHA functional class III 8 (57%) 0
B-type natriuretic peptide, ng/l 40 (10–428) 60 (13–79) 0.65
N-terminal pro–B-type
natriuretic peptide, ng/l
95 (13–1,018) 61 (12–141) 0.27
eGFR, ml/min/1.73 m2 87 33 96 17 0.48
Hemoglobin, g/l 137 10 146 14 0.08
ata are given as mean  SD, counts and percentages, or median (range).
ACEI  angiotensin-converting enzyme inhibitor; ARB  angiotensin-receptor blocker; eGFR 
stimated glomerular filtration rate; HFNEF  heart failure and normal ejection fraction; NYHA 
ew York Heart Association.ariance for repeated measures (mixed between-within subjects
f
vnalysis of variance) was performed. Pearson or Spearman
orrelation coefficients between parameters of interest were
alculated as appropriate. A p value 0.05 was considered
tatistically significant. Analysis was performed using a com-
ercially available software package (SPSS version 15.0, SPSS,
nc., Chicago, Illinois).
esults
atient characteristics. We studied an HFNEF popula-
ion with demographic features similar to those described in
ther studies and controls of similar age and sex (Table 1).
atients with HFNEF had higher body mass index and
ere more likely to be receiving antihypertensive and heart
ailure medications than were controls. The groups did not
ignificantly differ with regard to natriuretic peptide
oncentrations.
V structure and function. As shown in Table 2, and in
ccordance with previous studies, patients with HFNEF
ad smaller LV dimensions, more concentric LV geometry,
arger left atrial dimensions, lower systolic (except s=septal)
nd early diastolic mitral annular velocities, and higher E/e=
ompared with controls.
esting and exercise hemodynamics and gas exchange.
t rest (Table 3), heart rate, mean arterial pressure, right
trial pressure, mean pulmonary pressure, and PCWP did
ot differ between HFNEF patients and controls. However,
ardiac index and SVI were lower, systemic vascular resis-
ance index (SVRI) was higher, and pulmonary vascular
esistance index tended to be higher in patients. The partial
chocardiographic Characteristicsf Patients Wit HFNEF and ControlsTable 2 Echo ardiograph c Characteristicsof Patients With HFNEF and Controls
HFNEF
(n  14)
Controls
(n  8) p Value
LV end-diastolic volume index, ml/m2 46 8 58 20 0.05
LV end-systolic volume index, ml/m2 17 3 22 8 0.03
Relative wall thickness 0.41 0.08 0.33 0.06 0.03
LV ejection fraction, % 63 6 62 5 0.62
LV mass index, g/m2 83 16 95 29 0.28
Left atrial volume index, ml/m2 21.3 7.0 18.9 5.9 0.41
E/A ratio 0.95 0.37 1.26 0.55 0.13
Deceleration time, ms 224 63 226 80 0.94
s=septal, cm/s 7.0 1.2 7.8 1.8 0.20
s=lateral, cm/s 6.9 1.7 8.8 2.1 0.03
s=av, cm/s 6.9 1.2 8.3 1.5 0.03
e=septal, cm/s 6.1 1.5 9.0 3.1 0.007
e=lateral, cm/s 7.7 2.1 11.8 4.5 0.008
e=av, cm/s 6.9 1.6 10.4 3.7 0.005
E/e=septal 13.2 4.1 9.5 3.4 0.04
E/e=lateral 10.6 3.4 7.2 2.2 0.02
E/e=av 11.6 3.3 8.1 2.5 0.02
ata are given as mean  SD.
E/A ratio  ratio of the peak early (E) to peak late (A) diastolic transmitral velocities;
=septal/lateral/av  peak early diastolic annular velocity measured at the septal/lateral mitral
nnulus and the average of both; E/e=septal/lateral/av ratio of E to e=septal/lateral/av; HFNEF heart
ailure and normal ejection fraction; LV  left ventricular; s=septal/lateral/av  peak systolic annular
elocity measured at the septal/lateral mitral annulus and the average of both.
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Exercise Hemodynamics in HFNEF September 7, 2010:855–63ressure of arterial oxygen (82  16 mm Hg vs. 100  23
m Hg; p 0.046) and arterial (96 2% vs. 97 1%; p
.04) and mixed venous (71  4% vs. 74  4%; p  0.02)
xygen saturations were slightly lower in HFNEF patients
ompared with controls. The partial pressure of arterial
arbon dioxide (38  5 vs. 41  5; p  0.19) did not
ignificantly differ between the groups.
Patients with HFNEF stopped exercise earlier (5.5  2.4
in vs. 9.4  1.9 min; p  0.001), and at a significantly
ower work rate (0.63  0.29 W/kg vs. 1.13  0.49 W/kg;
 0.006) because of breathlessness and/or fatigue. Peak
eart rate, mean arterial pressure, mean pulmonary arterial
ressure, and PCWP at peak exercise were similar in
atients with HFNEF and controls (Table 3). Thus, the
CWP/peak work rate ratio was markedly higher in
FNEF compared with controls. Patients with NYHA
unctional class II and III had similar PCWP at rest (10 
mm Hg vs. 10  4 mm Hg; p  0.90) and peak exercise
24 4 mm Hg vs. 22 7 mm Hg; p 0.67), but patients
ith functional class III symptoms achieved a significantly
ower peak work rate (0.45  0.18 W/kg vs. 0.87  0.23
/kg; p  0.002), and tended to have a higher PCWP/
eak work rate ratio (59  35 mm Hg/W/kg vs. 30  13
m Hg/W/kg; p  0.08).
Peak exercise pulmonary vascular resistance index was also
igher in patients compared with controls (Table 3). Notably,
he partial pressure of arterial oxygen (88  19 mm Hg vs.
7  13 mm Hg; p  0.90) and arterial (96  2% vs. 97 
%; p  0.80), and mixed venous (51  11% vs. 45  6%;
Hemodynamics at Rest and Peak Exercise in PaTable 3 Hemodynamics at Rest and Peak E
Rest
Heart rate, beats/min
Right atrial pressure, mm Hg
Mean arterial pressure, mm Hg
Mean pulmonary artery pressure, mm Hg
PCWP, mm Hg
Pulmonary vascular resistance index, dyne·s/cm5/m2
Systemic vascular resistance index, dyne·s/cm5/m2
Cardiac index, l/min/m2
Stroke volume index, ml/m2
Peak exercise
Heart rate, beats/min
Percent predicted heart rate, %
Mean arterial pressure, mm Hg
Mean pulmonary artery pressure, mm Hg
PCWP, mm Hg
PCWP/work rate ratio, mm Hg/W/kg
Pulmonary vascular resistance index, dyne·s/cm5/m2
Systemic vascular resistance index, dyne·s/cm5/m2
Cardiac index, l/min/m2
Stroke volume index, ml/m2
Data are given as mean  SD.
HFNEF  heart failure and normal ejection fraction; PCWP  pulm 0.23) oxygen saturation at peak exercise did not differ vetween the groups. There was a trend toward a lower partial
ressure of arterial carbon dioxide (36 4 mm Hg vs. 40 3
m Hg; p  0.06) in patients compared with controls.
eterminants of exercise capacity. Calculated VO2, arte-
iovenous differences in oxygen content, and cardiac index
ncreased during exercise in both HFNEF patients and
ontrols (Fig. 1). As shown in Figure 1A, VO2 was slightly
ower at rest but markedly lower at peak exercise in patients
ompared with controls. This difference in peak VO2
etween the groups was predominantly due to a lower peak
xercise cardiac index in HFNEF patients, and only to a
inor degree was it due to a nonsignificantly lower arterio-
enous difference in oxygen content at peak exercise (Figs.
B and 1C).
The difference in peak exercise cardiac index between
atients and controls was mainly driven by a markedly lower
eak exercise SVI in patients (Fig. 2A), whereas peak heart
ate did not differ between the groups (Fig, 2B). The
ignificantly lower SVI response in patients occurred at
imilar PCWP levels (Fig. 2C). The SVRI decreased during
xercise in both groups but remained significantly higher in
atients than controls at peak exercise (Fig. 2D). The SVI
t peak exercise was closely and inversely related to SVRI at
est (r  0.64; p  0.001) and particularly SVRI peak
xercise (r  0.84; p  0.001).
pright noninvasive cardiopulmonary exercise testing.
ata from maximal upright exercise tests are presented in
able 4. As expected for a heart failure population, peak
ork rate and peak VO2 were lower, and the slope of the
s With HFNEF and Controlsse in Patients With HFNEF and Controls
HFNEF
(n  14)
Controls
(n  8) p Value
66 10 66 20 0.97
5 3 5 3 0.80
100 7 101 17 0.90
18 5 16 4 0.31
10 4 10 4 0.94
274 176 155 63 0.08
3,029 737 2,241 388 0.01
2.6 0.5 3.5 1.0 0.01
41 9 51 10 0.02
102 22 112 20 0.33
67 14 70 14 0.63
120 14 124 11 0.41
37 10 32 8 0.22
23 6 20 7 0.31
46 31 20 9 0.03
257 135 119 53 0.01
2,251 879 1,331 272 0.01
4.6 1.6 7.4 1.4 0.001
45 10 68 15 0.001
apillary wedge pressure.tientxercientilation to carbon dioxide output relationship was higher
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September 7, 2010:855–63 Exercise Hemodynamics in HFNEFn HFNEF patients compared with controls. In contrast to
upine exercise, which was submaximal in some subjects,
eak heart rate was significantly lower in HFNEF patients
ompared with controls. However, the heart rate response at
atched work rates did not significantly differ between
atients and controls (Fig. 3A), and the VO2/work rate
elationship at similar work rates did not differ between the
roups either (Fig. 3B).
/e= for the prediction of the exercise response. At rest,
here was no correlation between PCWP and E/e=septal (r 
.19; p  0.39), E/e=lateral (r  0.04; p  0.87), or E/e=av
r  0.12; p  0.59). During exercise, there was a similar
ncrease in both E and e=septal in both HFNEF patients and
Figure 1 Determinants of VO2
Changes in (A) oxygen uptake (VO2), (B) arteriovenous difference in oxygen
content (AVO2), and (C) cardiac index from rest to peak exercise in patients
with heart failure and normal ejection fraction (HFNEF [diamonds]) and controls
(squares). Error bars represent mean and SD. *p  0.05 versus controls;
#p  0.05 versus rest.ontrols (Figs. 4A and 4B); however, E/e=septal did not aignificantly increase in either group, and peak exercise
/e=septal did not significantly differ between patients and
ontrols (Fig. 4C). Individual data for patients and controls
re shown in Figure 5. There was no significant correlation
etween peak exercise E/e=septal and peak exercise PCWP
r  0.22; p  0.33) or the peak exercise PCWP/work rate
atio (r  0.12; p  0.61).
iscussion
n the present study, HFNEF patients were characterized
y a significantly reduced exercise capacity. However, the
ardiac output response to exercise was parallel in HFNEF
atients and control subjects at similar work rates, and the
rteriovenous difference in oxygen content at peak exercise
nd the VO2/work rate relationship at matched work rates
id not significantly differ between the groups, indicating
hat oxygen delivery was appropriate at the time at which
FNEF patients stopped exercise. Moreover, there was no
vidence of a ventilatory limitation or arterial desaturation.
he heart rate response during cardiopulmonary exercise
esting was also similar, or perhaps even exaggerated at low
orkloads, and during assessment of invasive exercise,
emodynamics heart rates were similar in both groups.
Thus, the difference in peak exercise cardiac index was
ainly due to a difference in SVI. In accordance with
revious studies, HFNEF patients were characterized by a
mall LV cavity and a concentric remodeling, and SVI was
ower already at rest. We did not measure LV volumes
uring exercise, but given the consistent observation that
uring exercise, LVEF in HFNEF either does not substan-
ially change or increases slightly but less than in controls
8,12,20), this also indicates a lower exercise LV end-
iastolic volume in HFNEF compared with controls. How-
ver, in contrast to recent studies using right atrial pacing
10,11) we saw no decrease in SVI.
The PCWP at rest was not different between patients and
ontrols, a finding that is in contrast to a previous study
20), which, however, included patients with features that
ould not be consistent with a contemporary diagnosis of
FNEF (2), namely, patients with an underlying cardio-
yopathy (cardiac amyloid or hypertrophic cardiomyopa-
hy) (20). We found that HFNEF patients showed a rapid
ncrease in PCWP at low SVI and at a low work rates, and
his was accompanied by an early cessation of exercise.
hus, we found that the peak PCWP to peak work rate
atio, rather than the peak PCWP, was a suitable parameter
o distinguish HFNEF patients and controls. However, in
ontrast to the general belief that an increase in LV filling
ressures is not observed in normal physiology, we observed a
imilar rise in PCWP in controls, albeit at a much higher
orkload and cardiac output. Notably, this is a normal PCWP
esponse during supine cycle exercise in this age group (21);
nd also, during upright exercise, PCWP increases substan-
t
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Exercise Hemodynamics in HFNEF September 7, 2010:855–63ially in healthy people, although the absolute peak exercise
CWP is lower than during supine exercise (22).
Our finding that HFNEF patients showed a higher slope
f the ventilation to carbon dioxide output relationship is
lso consistent with a rapid, early symptom-producing rise
n PCWP, although other mechanisms may contribute to
Figure 2 Hemodynamic Response to Exercise
Changes in (A) stroke volume index, (B) heart rate, (C) pulmonary capillary wedge
exercise in patients with heart failure and normal ejection fraction (HFNEF [diamon
controls; #p  0.05 versus rest.
ardiopulmonary Exercise Testingta in Patients With HFNEF and ControlsTable 4 C rdiopulmonary Exercise Te tingData in Patients With HFNEF and Controls
HFNEF
(n  10)
Controls
(n  8) p Value
FEV1, l 2.97 0.67 3.35 1.09 0.38
Percent predicted FEV1, % 96 10 108 22 0.15
Exercise time, min 9.5 2.2 11.8 2.3 0.048
Peak heart rate, beats/min 124 23 155 19 0.007
Percent predicted heart rate, % 82 14 98 11 0.02
Peak work rate, W/kg 1.02 0.43 2.24 1.28 0.01
Percent predicted peak VO2, % 67 19 99 38 0.03
Indexed peak VO2, ml/min/kg 15.1 4.9 26.6 12.5 0.02
VE/VCO2 slope 34.3 5.4 28.4 3.4 0.02
Breathing reserve, l 45 29 42 28 0.81
Peak exercise respiratory
exchange ratio
1.28 0.16 1.42 0.09 0.06
ata are mean  SD.
FEV1  forced expiratory volume in 1 s; HFNEF  heart failure and normal ejection fraction;a
E/VCO2 slope  slope of the relationship between minute ventilation and carbon dioxide output;
O2  oxygen uptake.entilator inefficiency in these patients. Borlaug et al. (12)
lso proposed that pulmonary congestion was a major
ontributory factor to exercise intolerance in HFNEF pa-
ients. However, unlike our study, they did not measure
nvasive hemodynamics; rather, lung blood volume was
aken as an index of pulmonary congestion, although there
as no evidence that this method could detect pulmonary
nterstitial congestion (12).
Noninvasive studies have suggested that increased arterial
oad in HFNEF patients is not matched by increased
yocardial contractility (14), and that the reduction in
VRI during exercise is lower compared with controls (12).
n the present invasive study, we have demonstrated a
igher SVRI in patients at rest and peak exercise and a very
lose inverse correlation between SVI and SVRI during
xercise. Given that HFNEF has been shown to be char-
cterized by complex abnormalities in LV systolic and
iastolic function as well as torsion and untwisting (9), and
iven that at least LV longitudinal myocardial velocities (s=
nd e=) are afterload dependent (23), it is possible that
fterload even has a direct impact on LV function in
FNEF.
Taken together, our data clearly support the concept that
small noncompliant left ventricle and a stiff arterial system
ure (PCWP), and (D) systemic vascular resistance index (SVRI) from rest to peak
nd controls (squares). Error bars represent mean and SD. *p  0.05 versuspress
ds]) are the key mechanisms underlying the symptoms in pa-
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hronotropic incompetence.
Our study also provides clinically important and novel
nformation on the utility of noninvasive markers proposed
or the diagnosis of HFNEF (17,24). We confirmed that
/e= at rest was higher in HFNEF patients than in controls,
ut this difference in E/e= did not reflect a difference in
CWP, which is in accordance with recent studies in
atients with hypertrophic cardiomyopathy and decompen-
ated heart failure with reduced LVEF (25). Thus, while a
igh E/e= appears to be a good marker of HFNEF, this is
ot because it reflects increased filling pressures at rest, but
ore likely because it indicates a low e= and, presumably,
lso more complex abnormalities of LV function (9). We
lso found that E/e=septal at peak exercise did not adequately
epresent changes in PCWP. A previous study had shown
hat E/e=septal during exercise identified patients with an
ncrease in LV end-diastolic pressure during exercise (26).
owever, that study included younger and unselected pa-
ients undergoing left-side heart catheterization, and as was
vident from the mild increase in heart rate, low level
Figure 3 Heart Rate and Oxygen
Uptake to Work Rate Response
(A) Heart rate response and (B) relationship between oxygen uptake and work
rate (VO2/work rate) for matched work rates in patients with heart failure
and normal ejection fraction (HFNEF [diamonds]) and controls (squares). Data
are shown until the time point when the first patient stopped exercise. Error
bars represent mean and SD. The p value for the interaction group *work rate
is given. ns  nonsignificant.xercise was used (26), which may explain the discrepantndings. Natriuretic peptide concentrations did not signif-
cantly differ between patients and controls, and that may be
elated to the small number of patients, to the typically
kewed distribution of natriuretic peptide concentrations,
nd to a higher body mass index being associated with lower
lasma concentrations.
tudy limitations. We studied a small number of partici-
ants. However, this was a comprehensive, and to the best
f our knowledge, the largest study investigating exercise
emodynamics in a typical elderly HFNEF population. In
ddition, we did not measure LV pressures directly. How-
ver, this would have required a femoral access in most
atients, and would have made exercise involving a large
art of the musculature impossible.
Figure 4 E/e=septal and Filling Pressures
Changes in (A) the peak early diastolic transmitral velocity (E), and (B) the
peak early diastolic annular velocity at the septal annulus (e=septal) and (C)
E/e=septal from rest to peak exercise in patients with heart failure and normal
ejection fraction (HFNEF [diamonds]) and controls (squares). Error bars repre-
sent mean and SD. *p  0.05 versus controls; #p  0.05 versus rest.
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e propose that HFNEF patients exhibit a rapid rise in
CWP at a much lower workload than that of age-matched
ontrols. Moreover, this occurs at a lower SVI and in the
etting of higher SVRI. The E/e=septal ratio does not
ccurately reflect the hemodynamic changes occurring dur-
ng exercise in HFNEF patients, and we suggest, therefore,
hat invasive hemodynamic studies with exercise are re-
uired to formally establish the pathophysiologic profile in
atients with suspected HFNEF and to evaluate the effects
f novel therapies.
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